Vemurafenib Active Not Recruiting Phase 2 Trials for Melanoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01754376Combined BRAF-Targeted Therapy & Immunotherapy for Melanoma